Christine Albert, M.D., MPH, director of the Center for Arrhythmia Prevention at Brigham and Women’s Hospital, and ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
March 19, 2019 — The Bristol-Myers Squibb-Pfizer Alliance announced results from the Phase 4 AUGUSTUS trial evaluating ...
The American College of Cardiology (ACC) released a list of the latest practice-changing presentations at the ACC.19 ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 18, 2019 — Researchers from the Stanford University School of Medicine presented preliminary results of the Apple ...
February 4, 2019 – Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
January 28, 2019 — Acutus Medical announced 12-month data from the UNCOVER-AF trial investigating the use of the AcQMap ...
January 21, 2019 — Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force ...
December 18, 2018 — Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
November 30, 2018 — Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and ...
Wilber Su, M.D., chief of cardiac electrophysiology, Banner University Medical Center, Phoenix, and clinical associate ...
November 7, 2018 — Here is a list of some of the key clinical trial presentations at the 2018 American Heart Association ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
October 9, 2018 — Biosense Webster Inc. recently received approval from the U.S. Food and Drug Administration (FDA) for ...
Advances in the technology of wearable cardiac monitors are improving both the experience of the patient and the ...